Steadman Philippon Research Institute

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Steadman Philippon Research Institute sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).

7 total trials 2 currently recruiting 1 completed early-phase tilt upper quartile by trial count

Steadman Philippon Research Institute: 7 sponsored US clinical trials, 2 recruiting.

Steadman Philippon Research Institute sponsors 7 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 1 completed. 0 of these trials are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Osteoarthritis, Knee, with 2 trials.

Upper-quartile sponsor footprint

Steadman Philippon Research Institute sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

7 total, page 1 of 1

RECRUITING NA

Home-Based Leg Dexterity Trainer for Management of Knee Osteoarthritis

NCT07397806
RECRUITING Phase 1

Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using Losartan

NCT06108063
ACTIVE NOT RECRUITING Phase 1

Senolytic Agent Improve the Benefit of Platelet-Rich Plasma and Losartan

NCT05025956
ACTIVE NOT RECRUITING Phase 1

Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis

NCT04815902
ACTIVE NOT RECRUITING Phase 1

Prospective Evaluation of PRP and BMC Treatment to Accelerate Healing After ACL Reconstruction

NCT04205656
TERMINATED Phase 1

Losartan to Improve Hip Microfracture

NCT04212650
COMPLETED Phase 1

Senolytic Drugs Attenuate Osteoarthritis-Related Articular Cartilage Degeneration: A Clinical Trial

NCT04210986

Phase Distribution

PhaseTrial count
Phase 1 6

Therapeutic Areas

Osteoarthritis, Knee 2
Femoroacetabular Impingement 1
Knee Arthroplasty, Total 1
Osteoarthritis of the Knee 1

What is open in the Steadman Philippon Research Institute pipeline

2 recruiting of 7 indexed (29% open); 1 completed (14%).

Phase mix: 0 late (III/IV) vs 6 early (I/II) (early-phase heavy).

Top condition: Osteoarthritis, Knee (2 trials), 3 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Steadman Philippon Research Institute: open-pipeline peers nationwide

Peers matched on 7 registered trials and 29% open enrollment, not the therapeutic-area sidebar.

Steadman Philippon Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0102030405060 0%10%20%30%40% Total trials Recruiting share Steadman Philippon Research Institute3M4Life Research89bioAbbott Diagnostics DivisionAlabama Physical Therapy & AcupunctureAlloSourceAlnylam PharmaceuticalsAnnovis Bio
Steadman Philippon Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Steadman Philippon Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 7 trials (± recruiting share)

Sponsors near 29% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Steadman Philippon Research Institute page

7 registered trials is a research-attention snapshot, not an endorsement of Steadman Philippon Research Institute or any single study.

  • 2 of Steadman Philippon Research Institute's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Osteoarthritis, Knee is the condition Steadman Philippon Research Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Osteoarthritis, Knee trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Steadman Philippon Research Institute pipeline card: 7 registered trials from official public datasets.Report a data error.